Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations

Author:

Hart Nicolas H.12345ORCID,Nekhlyudov Larissa6ORCID,Smith Thomas J.7ORCID,Yee Jasmine8ORCID,Fitch Margaret I.9ORCID,Crawford Gregory B.1011ORCID,Koczwara Bogda1213ORCID,Ashbury Fredrick D.1415ORCID,Lustberg Maryam B.1617ORCID,Mollica Michelle18ORCID,Smith Andrea L.19ORCID,Jefford Michael2021ORCID,Chino Fumiko22ORCID,Zon Robin2324ORCID,Agar Meera R.25ORCID,Chan Raymond J.24ORCID

Affiliation:

1. Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia

2. Caring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia

3. Exercise Medicine Research Institute, School of Medical and Health Science, Edith Cowan University, Perth, WA, Australia

4. Cancer and Palliative Care Outcomes Centre, School of Nursing, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia

5. Institute for Health Research, The University of Notre Dame Australia, Perth, WA, Australia

6. Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

7. Division of General Internal Medicine and Sidney Kimmel Comprehensive Cancer Center, John Hopkins Medical Institutions, Baltimore, MD

8. Centre for Medical Psychology and Evidence-Based Decision-Making, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia

9. School of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, ON, Canada

10. Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia

11. Northern Adelaide Local Health Network, Adelaide, SA, Australia

12. Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia

13. Flinders Cancer and Innovation Centre, Flinders Medical Centre, Adelaide, SA, Australia

14. VieCure, Clinical and Scientific Division, Greenwood Village, CO

15. Department of Oncology, University of Calgary, Calgary, ON, Canada

16. Department of Medicine, School of Medicine, Yale University, New Haven, CT

17. Medical Oncology Division, Yale Cancer Centre, New Haven, CT

18. Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD

19. The Daffodil Centre and University of Sydney: a joint venture with Cancer Council NSW, Sydney, NSW, Australia

20. Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia

21. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia

22. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

23. Michiana Hematology-Oncology, Mishawaka, IN

24. Cincinnati Cancer Advisors, Norwood, OH

25. IMPACCT Research Centre, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia

Abstract

PURPOSE People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer. METHODS A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process. RESULTS A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations. CONCLUSION Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts. Additional information is available at www.mascc.org , www.asco.org/standards and www.asco.org/survivorship-guidelines .

Publisher

American Society of Clinical Oncology (ASCO)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3